These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30507770)

  • 41. Effects of pediatric blood lead surveillance on Navy population health (1995-2001).
    Bohnker BK; Schwartz E; McGinnis J; Sack D; Craft N
    Mil Med; 2003 May; 168(5):391-3. PubMed ID: 12775175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Pay for Success" Financing and Home-Based Multicomponent Childhood Asthma Interventions: Modeling Results From the Detroit Medicaid Population.
    Lantz PM; Miller G; Rhyan CN; Rosenbaum S; Ku L; Iovan S
    Milbank Q; 2018 Jun; 96(2):272-299. PubMed ID: 29870111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Childhood blood lead screening in Arkansas: recommendations for health care providers.
    West R
    J Ark Med Soc; 1999 May; 95(12):532-7. PubMed ID: 10341482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An innovative blood lead screening program for Indian children.
    Howell EM; Russette L
    Public Health Rep; 2004; 119(2):141-3. PubMed ID: 15192900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Childhood lead poisoning in Washington state: A statewide survey.
    Ossiander EM; Mueller MM; VanEnwyk J
    Arch Environ Occup Health; 2005; 60(1):25-30. PubMed ID: 16961005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Follow-up of children suffering from lead poisoning or at risk of lead poisoning in Greater Paris, 1992--2002.
    Rollin L; Carré N; Garnier R;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):391-7. PubMed ID: 19013038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Markers for primary care: missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city Medicaid-eligible children.
    Fairbrother G; Friedman S; DuMont KA; Lobach KS
    Pediatrics; 1996 Jun; 97(6 Pt 1):785-90. PubMed ID: 8657515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The predictive value of self-report questions in a clinical decision rule for pediatric lead poisoning screening.
    Kaplowitz SA; Perlstadt H; D'Onofrio G; Melnick ER; Baum CR; Kirrane BM; Post LA
    Public Health Rep; 2012; 127(4):375-82. PubMed ID: 22753980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing lead poisoning risk assessment methods: census block group characteristics vs. zip codes as predictors.
    Kaplowitz SA; Perlstadt H; Perlstadt H; Post LA
    Public Health Rep; 2010; 125(2):234-45. PubMed ID: 20297750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of elevated blood lead levels among children living in foster care, their siblings, and the general population.
    Chung EK; Webb D; Clampet-Lundquist S; Campbell C
    Pediatrics; 2001 May; 107(5):E81. PubMed ID: 11331731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Department of Defense blood lead level survey program for young children.
    Burkhalter E; Butler W
    Mil Med; 1996 Nov; 161(11):687-90. PubMed ID: 8961725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of a Medicaid primary care provider and preventive care on pediatric hospitalization.
    Gadomski A; Jenkins P; Nichols M
    Pediatrics; 1998 Mar; 101(3):E1. PubMed ID: 9481020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood lead screening.
    Feinberg AN; Cummings CK
    Clin Pediatr (Phila); 2005 Sep; 44(7):569-74. PubMed ID: 16151561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood lead levels in Mississippi children.
    Cox RD; Kyle PB; Brackin B; Snazelle T; Surkin J
    J Miss State Med Assoc; 2010 Aug; 51(8):206-10. PubMed ID: 21365977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update of the Blood Lead Reference Value - United States, 2021.
    Ruckart PZ; Jones RL; Courtney JG; LeBlanc TT; Jackson W; Karwowski MP; Cheng PY; Allwood P; Svendsen ER; Breysse PN
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1509-1512. PubMed ID: 34710078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to the US FDA LeadCare Testing Systems Recall and CDC Health Alert.
    Mason J; Ortiz D; Pappas S; Quigley S; Yendell S; Ettinger AS
    J Public Health Manag Pract; 2019; 25 Suppl 1, Lead Poisoning Prevention(Suppl 1 LEAD POISONING PREVENTION):S91-S97. PubMed ID: 30507776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of lead poisoning among two-year-old children in Vermont.
    Paulozzi LJ; Shapp J; Drawbaugh RE; Carney JK
    Pediatrics; 1995 Jul; 96(1 Pt 1):78-81. PubMed ID: 7596728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The accuracy of a lead questionnaire in predicting elevated pediatric blood lead levels.
    France EK; Gitterman BA; Melinkovich P; Wright RA
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):958-63. PubMed ID: 8790128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lead poisoning in children.
    Warniment C; Tsang K; Galazka SS
    Am Fam Physician; 2010 Mar; 81(6):751-7. PubMed ID: 20229974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parental perceptions of barriers to blood lead testing.
    Polivka BJ; Gottesman MM
    J Pediatr Health Care; 2005; 19(5):276-84. PubMed ID: 16202835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.